Group One Trading
VRCA icon

Group One Trading’s Verrica Pharmaceuticals VRCA Stock Holding History

Group One Trading’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,090
Closed -$59.3K – 8028
2024
Q3 		$59.3K Sell
4,090
-1,280
-24% -$57.6K ﹤0.01% 4534
2024
Q2 		$391K Buy
5,370
+5,360
+53,600% +$412K ﹤0.01% 2799
2024
Q1 		$592 Sell
10
-960
-99% -$53K ﹤0.01% 6715
2023
Q4 		$71K Buy
+970
New +$39.9K ﹤0.01% 4769
2023
Q3 		– Sell
-4,230
Closed -$244K – 8379
2023
Q2 		$244K Sell
4,230
-2,870
-40% -$174K ﹤0.01% 3733
2023
Q1 		$462K Buy
7,100
+7,000
+7,000% +$423K ﹤0.01% 2851
2022
Q4 		$2.75K Sell
100
-50
-33% -$1.33K ﹤0.01% 6549
2022
Q3 		$4K Buy
150
+90
+150% +$3.08K ﹤0.01% 6961
2022
Q2 		$1K Buy
+60
New +$3.02K ﹤0.01% 7638
2021
Q4 		– Sell
-40
Closed -$5K – 8901
2021
Q3 		$5K Buy
+40
New +$4.49K ﹤0.01% 7762

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's VRCA Position: Q1 2026 in Review

Group One Trading sold out of Verrica Pharmaceuticals (VRCA) in Q1 2026, closing a stake of 3 shares — an estimated $25 sold.

Group One Trading first reported a position in VRCA in Q3 2021 and held it in 14 quarters. The position peaked at $53.5K in Q3 2023. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • Group One Trading reported no remaining Verrica Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3 Verrica Pharmaceuticals shares in Q1 2026, an estimated $25.
  • Group One Trading first reported a position in Verrica Pharmaceuticals in Q3 2021 and held it in 14 quarters.
  • Group One Trading's Verrica Pharmaceuticals position peaked at $53.5K in Q3 2023.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.